Target intelligence / Profile preview

Gut microbial ecosystem and host immune system

Molecular classification
Other (complex biological ecosystem, not a molecule or single classifiable protein), May include: receptors (TLRs), immune cell populations, bacterial metabolites, epithelial barrier proteins, immunoglobulins (e.g., IgA), Not directly classified as "Enzyme,", "Receptor," etc.
01

Overview

The **gut microbial ecosystem and host immune system** constitute a dynamic, interdependent network where trillions of microbes interact with the host’s innate and adaptive immune components through direct cell contact and vast arrays of metabolites. This crosstalk is fundamental to health, affecting nutrient absorption, epithelial barrier function, immune development, and protection against pathogens. Disruptions in these interactions (“dysbiosis”) can result in inflammation, autoimmunity, metabolic disturbances, infection, and even influence cancer progression and therapeutic outcomes. The ecosystem is so complex that targeting the entire system pharmacologically is not practical; instead, research is focused on modifying specific microbiota members, their metabolites, or host immune pathways.

Other names
Gut microbiota and immune systemMicrobiome-immune axisIntestinal microbiome and host immunityMicrobiota-gut-immune crosstalkGut-brain-immune axis (when brain interactions considered)
02

Mechanism of action

Modulation of microbial composition and metabolite production (probiotics, FMT, antibiotics); Regulation of host immune cell (T cell, B cell, dendritic cell) differentiation via microbial metabolites (SCFAs, ATP, polysaccharides); Restoration of epithelial barrier integrity; Enhancement or suppression of inflammatory responses

03

Biological functions

Maintenance of intestinal homeostasisTraining and modulation of innate and adaptive immunityProtection against infectionNutrient absorption and metabolismRegulation of inflammatory signalingShaping immunoglobulin repertoires (e.g., secretory IgA)T cell differentiation (Treg, Th1, Th17)Maintenance of epithelial barrier integrity
04

Disease associations

Inflammatory diseases (e.g., IBD)Autoimmune diseases (type 1 diabetes, multiple sclerosis)Cancer (tumor immune surveillance, chemotherapy response)Cardiovascular diseaseMetabolic syndrome, type 2 diabetesInfection susceptibilityTransplant outcomes (e.g., graft-versus-host disease)
05

Safety considerations

Disruption of microbial balance (dysbiosis) can lead to increased infection, inflammation, and immune dysregulationAntibiotic overuse reduces diversity, can promote resistant/pathogenic strainsFecal microbiota transplantation risks include transmission of infectionsPotential exacerbation of autoimmunity with immune modulationOff-target effects and unpredictable outcomes due to complex ecosystem
06

Interacting drugs

Probiotics/prebiotics

5 more in the full profile.

07

Biomarkers

Microbial diversity indices (e.g., α/β-diversity)Short-chain fatty acids (e.g., butyrate) levelsSecretory IgA concentrationBacterial taxa abundances (specific beneficial/harmful species)Cytokine profiles (IL-10, IL-17, etc.)Plasma endotoxin levels (marker of barrier disruption/inflammation)

Beyond the preview

Go deeper on Gut microbial ecosystem and host immune system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbial ecosystem and host immune system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call